Quarterly Transactions Made in Spdr Ser Tr Spdr S&P Biotech E (XBI)
This table provides information about the institutional ownership of Spdr Ser Tr Spdr S&P Biotech E (XBI). The information is specifically focused on institutions that hold shares of SPDR SER TR SPDR S&P BIOTECH E.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q1 2021 | 4,504,638 | 3,031,167 | 7,535,805 | 13,229,551 | 705,623 | 13,935,174 | -6,399,369 | |
| Q2 2021 | 3,660,850 | 15,032,234 | 18,693,084 | 9,350,831 | 603,916 | 9,954,747 | 8,738,337 | |
| Q3 2021 | 4,767,662 | 18,108,968 | 22,876,630 | 4,690,505 | 698,591 | 5,389,096 | 17,487,534 | |
| Q4 2021 | 9,145,702 | 9,107,572 | 18,253,274 | 9,152,908 | 1,089,373 | 10,242,281 | 8,010,993 | |
| Q1 2022 | 25,073,517 | 5,641,224 | 30,714,741 | 20,189,927 | 1,281,376 | 21,471,303 | 9,243,438 | |
| Q2 2022 | 18,131,383 | 9,520,590 | 27,651,973 | 15,560,530 | 4,290,761 | 19,851,291 | 7,800,682 | |
| Q3 2022 | 8,658,219 | 5,165,464 | 13,823,683 | 16,025,434 | 28,899 | 16,054,333 | -2,230,650 | |
| Q4 2022 | 14,996,398 | 9,494,260 | 24,490,658 | 9,187,237 | 8,290 | 9,195,527 | 15,295,131 | |
| Q1 2023 | 21,809,586 | 2,069,865 | 23,879,451 | 17,120,053 | 72 | 17,120,125 | 6,759,326 | |
| Q2 2023 | 16,147,591 | 2,135,854 | 18,283,445 | 16,285,542 | 0 | 16,285,542 | 1,997,903 | |
| Q3 2023 | 12,781,434 | 3,339,476 | 16,120,910 | 4,960,142 | 26,735 | 4,986,877 | 11,134,033 | |
| Q4 2023 | 10,027,888 | 9,974,012 | 20,001,900 | 24,938,868 | 72 | 24,938,940 | -4,937,040 | |
| Q1 2024 | 27,682,482 | 3,652,066 | 31,334,548 | 10,080,091 | 0 | 10,080,091 | 21,254,457 | |